Detection of HLA-B*48:50 in a Chinese individual.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
09 2020
Historique:
received: 30 04 2020
revised: 06 05 2020
accepted: 06 05 2020
pubmed: 13 5 2020
medline: 22 6 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

HLA-B*48:50 differs from HLA-B*48:01:01 (467C->A, S132Y).

Identifiants

pubmed: 32396657
doi: 10.1111/tan.13925
doi:

Substances chimiques

HLA-B Antigens 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-349

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Yan Zhang (Y)

Department of Pathology and Lab Medicine, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.

Jiying Wang (J)

Department of Pathology and Lab Medicine, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.

Qinghua Li (Q)

Department of Pathology and Lab Medicine, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.

Hui Wei (H)

Department of Pathology and Lab Medicine, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.

Xiaojing Wang (X)

Department of Pathology and Lab Medicine, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH